• Faculty of Clinical Research (FCR)
  • Global accredited training & certification provider cleanindia
  • Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India.
  • ApprovedTraining Partner of Food Safety and Standards Authority of India (FSSAI)
  • An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India
  • Empanelled under Ministry of Horticulture and Food Processing, Govt. of Uttar Pradesh
  • Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC) set up by National Skill Development Corporation (NSDC)
  • Conferred with QUALITY COUNCIL OF INDIA (QCI) – D.L. SHAH NATIONAL QUALITY AWARD & ASSOCHAM Services Excellence Award 2017
  • Trusted by organizations & training participants in over 30 countries
    Training | Certification | Education | Research
  •  

Honourable Dr. G. N. Singh, Drug Controller General of India presented a Momento by our Director Mr. Syed S. Abbas & Principal Advisor Mr. Vinod Arora on the launch of our Computer System Validation (CSV) programme

IGMPI is conferred with ASSOCHAM Services Excellence Award 2017: Our Directors Mr Syed S. Abbas & Mrs Rafat Abedi, Chief Advisor Dr Mahesh Gupta, Advisor Mr Amitabh Srivastava are being honoured by the Chief Guest & Honorable Member of Parliament Dr. Udit Raj

 

Flawed Study Designs in Clinical Trial Study leads to Confounding End-Points

Flawed Study Designs in Clinical Trial Study leads to Confounding End-Points

Director, FDA John Whyte stated in a research study that pharmaceutical industry miss on grasping patient centricity as they are not choosing clinically meaningful trial outcomes. He suggested that biopharmaceutical industry needs to “better listen to patients, rather than talking at them.”

He emphasized that patient conversation is very important in identifying preliminary research outcomes. According to a research study, 152,000 unique conversations between asthma patients from February 2006 through June 2017 revealed startling insights. For example: as per research approach, the most common topic of discussion with asthma patients includes lung and respiratory infections. However, the study exhibits that allergies, medications, and walking are topics of interest between patients.The study indicates that patients are discussing allergy related topics including rhinitis, and hay fever.

The studies emphasize the need to use aggregate technology in order to provide optimized study end‑points. The process of discussing strategies with patients before a study start-up will automatically result in a better study design. The table below shows best fit conversations among patient.